Search Results - "Horvath, Gyorgy"
-
1
Cancer odor in the blood of ovarian cancer patients: a retrospective study of detection by dogs during treatment, 3 and 6 months afterward
Published in BMC cancer (26-08-2013)“…In recent decades it has been noted that trained dogs can detect specific odor molecules emitted by cancer cells. We have shown that the same odor can also be…”
Get full text
Journal Article -
2
Characteristic odour in the blood reveals ovarian carcinoma
Published in BMC cancer (24-11-2010)“…Ovarian carcinoma represents about 4% of all cancers diagnosed in women worldwide. Mortality rate is high, over 50%, mainly due to late diagnosis. Currently…”
Get full text
Journal Article -
3
Application of High-Throughput Next-Generation Sequencing for HLA Typing on Buccal Extracted DNA: Results from over 10,000 Donor Recruitment Samples
Published in PloS one (31-10-2016)“…Unambiguous HLA typing is important in hematopoietic stem cell transplantation (HSCT), HLA disease association studies, and solid organ transplantation…”
Get full text
Journal Article -
4
Human Ovarian Carcinomas Detected by Specific Odor
Published in Integrative cancer therapies (01-06-2008)“…The high mortality rate associated with ovarian carcinoma is mainly owing to late diagnosis. It is thus essential to develop inexpensive and simple methods for…”
Get full text
Journal Article -
5
External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma: a prospective, randomized study--quality-of-life analysis
Published in International journal of gynecological cancer (01-09-2012)“…A combination of vaginal brachytherapy and external beam radiotherapy was compared with brachytherapy alone in medium-risk endometrial carcinomas…”
Get more information
Journal Article -
6
Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors
Published in European journal of cancer (1990) (01-11-2006)“…It is difficult to predict the clinical outcome for patients with ovarian cancer. However, the use of biomarkers as additional prognostic factors may improve…”
Get full text
Journal Article -
7
A study of docetaxel weekly or every three weeks in combination with carboplatin as first line chemotherapy in epithelial ovarian cancer: Hematological and non-hematological toxicity profiles
Published in Oncology letters (01-04-2013)“…The purpose of this study was to compare the toxicity profiles of docetaxel administered on a weekly schedule and the standard three-week schedule in the…”
Get full text
Journal Article -
8
A phase II study of docetaxel weekly in combination with carboplatin every three weeks as first line chemotherapy in stage IIB-IV epithelial ovarian cancer: Neurological toxicity and quality-of-life evaluation
Published in International journal of oncology (01-03-2012)“…The purpose of this study was to assess the response rate, toxicity, progression-free survival (PFS) and overall survival (OS) in a series of advanced stage…”
Get full text
Journal Article -
9
Ergonomic Design Using Quality Function Deployment and Design of Experiments
Published in Forest products journal (01-07-2013)“…User needs relating to products are expressed in the language of customers. Designers are facing the challenge of answering the question of how relatively…”
Get full text
Journal Article -
10
Phase II study of docetaxel weekly in combination with carboplatin every 3 weeks as first-line chemotherapy in stage IIB to stage IV epithelial ovarian cancer
Published in International journal of gynecological cancer (01-01-2012)“…The purpose of this study was to assess the response rate, toxicity, progression-free survival, and overall survival in a series of patients with…”
Get more information
Journal Article -
11
Specific Copy Number Alterations Associated with Docetaxel/Carboplatin Response in Ovarian Carcinomas
Published in Anticancer research (01-11-2010)“…The continued high recurrence and mortality rate in ovarian cancer is a significant problem and the major obstacle in the treatment of ovarian cancer patients…”
Get full text
Journal Article -
12
External Pelvic and Vaginal Irradiation Versus Vaginal Irradiation Alone as Postoperative Therapy in Medium-Risk Endometrial Carcinoma—A Prospective Randomized Study
Published in International journal of radiation oncology, biology, physics (01-03-2012)“…Purpose To evaluate the value of adjuvant external beam pelvic radiotherapy as adjunct to vaginal brachytherapy (VBT) in medium-risk endometrial carcinoma,…”
Get full text
Journal Article -
13
Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up
Published in Acta obstetricia et gynecologica Scandinavica (01-01-2008)“…To evaluate long-term survival and prognostic factors for all epithelial ovarian cancer (EOC) patients after adjuvant treatment with paclitaxel and…”
Get more information
Journal Article -
14
Usefulness of Current Risk Groups in the Treatment of Surgically Staged Endometrial Carcinomas; A Population-based Study from Western Sweden
Published in Anticancer research (01-05-2009)“…Background: Endometrial carcinoma is the most common malignancy of the female genital tract and its incidence is increasing. However, treatment results have…”
Get full text
Journal Article -
15
mdr-1 Single Nucleotide Polymorphisms in Ovarian Cancer Tissue: G2677T/A Correlates with Response to Paclitaxel Chemotherapy
Published in Clinical cancer research (01-02-2006)“…Purpose: P-glycoprotein, encoded by the mdr-1 gene, confers multidrug resistance to a variety of antineoplastic agents, e.g., paclitaxel. Recently, different…”
Get full text
Journal Article -
16
A grounded theory exploration of the first visit to a cancer clinic—strategies for achieving acceptance
Published in European journal of oncology nursing : the official journal of European Oncology Nursing Society (01-09-2005)“…The purpose of this study was to investigate cancer patients’ experiences of their first visit to a cancer clinic. Nine patients with various cancer diagnoses…”
Get full text
Journal Article -
17
Sequential topotecan and oral etoposide in recurrent ovarian carcinoma pretreated with platinum-taxane : Results from a multicenter phase I/II study
Published in Cancer (01-04-2005)“…The objectives of this study were to determine the maximum tolerable dose (MTD), toxicity, efficacy, and feasibility of a sequential regimen of fixed-dose…”
Get full text
Journal Article -
18
Differential distribution of tocopherols and tocotrienols in photosynthetic and non-photosynthetic tissues
Published in Phytochemistry (Oxford) (01-06-2006)“…Tocopherols and tocotrienols are tocochromanols that differ with respect to the saturation state of their isoprenoid side chain. Tocopherols are found in…”
Get full text
Journal Article -
19
ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel
Published in Journal of pharmaceutical sciences (01-06-2008)“…P-glycoprotein (P-gp), encoded by the ABCB1 gene, confers multi-drug resistance to a variety of antineoplastic agents, for example, paclitaxel. Recently, the…”
Get more information
Journal Article -
20
Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas
Published in International journal of cancer (01-11-2008)“…The mortality rate for patients with ovarian carcinomas is high and the available prognostic factors are insufficient. The use of biomarkers may contribute to…”
Get full text
Journal Article